Literature DB >> 24683034

Nanomedicine: the promise and challenges in cancer chemotherapy.

Youssef W Naguib1, Zhengrong Cui.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24683034     DOI: 10.1007/978-94-017-8739-0_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

1.  Selective depletion of cultured macrophages by magnetite nanoparticles modified with gelatin.

Authors:  Yoshihiro Komohara; Ryuta Kawauchi; Erika Makiyama; Kazuki Mikami; Hasita Horlad; Yukio Fujiwara; Tetsuya Kida; Motohiro Takeya; Takuro Niidome
Journal:  Exp Ther Med       Date:  2017-06-21       Impact factor: 2.447

Review 2.  Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.

Authors:  Brittany E Givens; Youssef W Naguib; Sean M Geary; Eric J Devor; Aliasger K Salem
Journal:  AAPS J       Date:  2018-10-10       Impact factor: 4.009

3.  Co-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors.

Authors:  Manu M Joseph; S R Aravind; Suraj K George; Raveendran K Pillai; S Mini; T T Sreelekha
Journal:  Transl Oncol       Date:  2014-10-24       Impact factor: 4.243

4.  Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice.

Authors:  Aml I Mekkawy; Youssef W Naguib; Suhaila O Alhaj-Suliman; Emad I Wafa; Kareem Ebeid; Timothy Acri; Aliasger K Salem
Journal:  Int J Pharm       Date:  2021-07-10       Impact factor: 6.510

Review 5.  Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.

Authors:  Zhe Chen; Yuanqiang Zheng; Yanchun Shi; Zhengrong Cui
Journal:  Int J Nanomedicine       Date:  2018-01-09

6.  Modified Spraying Technique and Response Surface Methodology for the Preparation and Optimization of Propolis Liposomes of Enhanced Anti-Proliferative Activity against Human Melanoma Cell Line A375.

Authors:  Hesham Refaat; Youssef W Naguib; Mahmoud M A Elsayed; Hatem A A Sarhan; Eman Alaaeldin
Journal:  Pharmaceutics       Date:  2019-10-28       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.